Catalent Stock Predictions

Healthcare > Drug Manufacturers - Specialty & Generic

Buy CTLT

*Your capital is at risk

$63.49

+0 (+0%)

At Close: Mar 14, 2025

Currently predicting for Thu, 4 Jun 2026

CTLT Prediction Chart

CTLT Predictions History

Latest community submissions for CTLT.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Greg Kovalick @GregKovalick.124195	Nov 16, 2020	$120.61 +14.47%	$105.36	X	85.53%	1
GoldenNugget Pro	May 7, 2019	$45.37 +1.51%	$44.69	X	98.49%	0
NameNotImportant Pro	May 6, 2019	$46.28 -0.49%	$46.51	X	99.51%	4
GoldenNugget Pro	May 6, 2019	$44.02 -5.36%	$46.51	X	94.64%	0
NameNotImportant Pro	May 3, 2019	$44.55 -2.71%	$45.79	X	97.29%	0
NameNotImportant Pro	Apr 29, 2019	$45.30 +0.27%	$45.18	X	99.73%	4

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CTLT with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CATALENT INC

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by